Literature DB >> 8007598

Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat.

J Bover1, M Rodriguez, P Trinidad, A Jara, M E Martinez, L Machado, F Llach, A J Felsenfeld.   

Abstract

Secondary hyperparathyroidism (2 degree HPT) develops as a result of renal failure. Hypocalcemia, phosphorus retention, calcitriol deficiency and skeletal resistance to the calcemic action of parathyroid hormone (PTH) are closely interrelated pathogenic factors important for the development of 2 degrees HPT in renal failure. Since previous studies have mainly focused on advanced renal failure, only limited data are available in early renal failure. The goal of the present study was to evaluate how alterations in the dietary calcium and phosphorus composition affect the factors known to contribute to the genesis of 2 degrees HPT in early and more advanced renal failure. To achieve this goal, graded differences in renal function were surgically induced in 453 rats while the dietary content of calcium and phosphorus was varied. Three different diets were used: (1) a high phosphorus diet (HPD), to induce phosphorus retention and stimulate 2 degrees HPT; (2) a high calcium diet (HCaD), to inhibit calcitriol synthesis; and (3) a moderate calcium-moderate phosphorus diet (MCaPD), to separate the effects of high dietary phosphorus and calcium. Based on the serum creatinine (SCr) concentration rats were assigned to one of four different groups: (1) normal renal function (SCr < or = 0.3 mg/dl); (2) mild renal failure (SCr 0.4 to 0.6 mg/dl); (3) moderate renal failure (SCr 0.7 to 0.8 mg/dl); or (4) advanced renal failure (SCr > or = 0.9 mg/dl). As the severity of renal failure increased, progressive 2 degrees HPT developed in each of the dietary groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8007598     DOI: 10.1038/ki.1994.129

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure.

Authors:  Stephen Damment; Roger Secker; Victor Shen; Victor Lorenzo; Mariano Rodriguez
Journal:  Nephrol Dial Transplant       Date:  2010-11-22       Impact factor: 5.992

2.  Phosphate Additive Avoidance in Chronic Kidney Disease.

Authors:  David E St-Jules; David S Goldfarb; Mary Lou Pompeii; Mary Ann Sevick
Journal:  Diabetes Spectr       Date:  2017-05

3.  Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

Authors:  Kenneth R Phelps
Journal:  Nutrients       Date:  2017-04-26       Impact factor: 5.717

Review 4.  Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence.

Authors:  M Jesús Lloret; César Ruiz-García; Iara Dasilva; Mónica Furlano; Yaima Barreiro; José Ballarín; Jordi Bover
Journal:  Patient Prefer Adherence       Date:  2013-11-06       Impact factor: 2.711

Review 5.  Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation.

Authors:  Jordi Bover; Mario Cozzolino
Journal:  Kidney Int Suppl (2011)       Date:  2011-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.